Literature DB >> 1686421

[Neurohumoral changes in patients with heart failure treated chronically with beta-blockers].

A V Mattioli1, G Mattioli.   

Abstract

Long-term beta-blocker therapy may be useful in some patients affected by chronic heart failure. In a group of 15 patients with chronic heart failure of different origin we evaluated clinical, hemodynamic and neurohormonal features after 1 year of therapy. All patients were treated with atenolol at dosage of 50 mg/die. We observed a better ejection fraction by radionuclide angiography after 1 year of treatment. There was an increase of exercise time and VO2 max evaluated by cycloergometer test. There was a decrease of mean pulmonary artery pressure, of pulmonary vascular resistance and of right atrial pressure. Plasmatic norepinephrine decreased from 1294 +/- 568 to 574 +/- 33 pg/l. Our results suggest that patients who well tolerated chronic beta-blockade show an improvement of performance parameters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686421

Source DB:  PubMed          Journal:  Cardiologia        ISSN: 0393-1978


  1 in total

1.  Prevalence and prognostic significance of adrenergic escape during chronic beta-blocker therapy in chronic heart failure.

Authors:  Lutz Frankenstein; Christian Zugck; Dieter Schellberg; Manfred Nelles; Hanna Froehlich; Hugo Katus; Andrew Remppis
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.